Navigation Links
Researchers Studying Novel Therapy For Prostate Cancer

A team of University of Iowa Health Care researchers has launched an important clinical trial of a novel therapeutic that may eventually lead to new treatments for men// diagnosed with prostate cancer.

The Ad5-TRAIL gene therapy for prostate cancer research trial is a Phase I study designed to test the optimal dosage at which the therapeutic agent can safely be given to patients.

The clinical study is being co-led by Thomas Griffith, Ph.D., an associate professor in the UI Department of Urology, and Richard Williams, M.D., the Rubin H. Flocks Chair in Urology and professor and head of the UI Department of Urology.

"This is the first use of this type of anti-cancer agent which was developed at the University of Iowa. This new gene therapy may help us successfully manage patients with high-risk prostate cancer," Griffith said. "Ideally, we hope to be able to say at the conclusion of this trial that this novel agent is safe and performs as intended by causing the death of prostate tumor cells with no harm to normal cells. However, being at the initial stages of the trial, it is premature to make any claims until the data is analyzed."

Researchers injected the investigational therapeutic into the cancerous prostates of three patients. Then, following a 10-day waiting period, surgeons removed the prostates and are evaluating the results.

"The preliminary results appear promising," Williams said. "The patients have tolerated the treatment without any serious side effects, which we hope will permit us to proceed with the research process."

Investigators plan to enroll up to 12 additional participants in the Phase I segment of the study.

"While the vaccine is not intended to be curative at this stage, the role of the research participants is critically important to what is truly a team effort. Without the involvement of our patients, we could not succeed," said Timothy Ratliff, Ph.D., the An
'"/>




Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
(Date:12/16/2009)... 16 In a random sampling of ... ME, and Philadelphia, PA, numerous pallets tested positive ... that could potentially create health hazards for consumers. ... previous wood pallet testing conducted in the Washington-Baltimore ... risks to our nation,s food supply from wood ...
(Date:12/16/2009)... Boston University School of Medicine,s (BUSM) Pulmonary ... from the National Heart, Lung, and Blood Institute ... patients with lung disease. , Darrell Kotton, ... Gustavo Mostoslavsky, MD, PhD, assistant professor of medicine, ... award. Together Kotton and Mostoslavsky lead a multicenter ...
(Date:12/16/2009)... Satisfaction, New Partners and Global Market Expansion , ... ... provider of Feedback Analytics to Web sites and companies, today announced ... 25,000 new customers. Since its launch on July 2008, Kampyle ... 60 languages, and amassed more than 30,000 customers in 191 countries., ...
(Date:12/16/2009)... 16 For ages, people from around the ... properties. Its soothing waters have a reputation that dates ... involvement with miracles. Now, with the introduction of two ... can enjoy the legendary benefits of Dead Sea salt ... lines contain all-natural Dead Sea salt and essential oils ...
(Date:12/16/2009)... While many of the,pharma companies are struggling ... and inmarket drugs, MarketsandMarkets on the other ... players. These pharma,forecasting solutions are designed for ... phase,III. These have a substantial impact on ... strategy, manufacturing planning, sales force,promotion, and planning. ...
Breaking Medicine News(10 mins):Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 2Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 3Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 4Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 2Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 3Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 4Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 5Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3
... KIRKLAND, Wash. and CHARLESTON, S.C., Dec. 20 ... care insurance,brokerage, has more than quadrupled in size ... support staff. That just one sign of what,s,happening ... the company,s,experience., *(PHOTO 72dpi: Send2Press.com/mediaboom/07-0807-LTCTruesdell_72dpi.jpg), *(Photo ...
... Significantly Raised Platelet Counts and,Lowered Bleeding Risk in ... Chronic Idiopathic Thrombocytopenic Purpura (ITP), PHILADELPHIA and ... London) today announced the submission of a New,Drug ... Drug Administration,(FDA) for approval to market PROMACTA(TM) (eltrombopag). ...
... Whip,Roy Blunt (Mo.) issued the following statement this afternoon ... Health Insurance,Program (SCHIP) through March 2009:, "On this, ... of the 110th,Congress, the majority finally decided to adopt ... to extend the current SCHIP program,through the rest of ...
... Join 5 Million People in Over 80 Countries Who ... What began in a,modest Missouri church has exploded ... resolution for 2008. People are giving up complaining,and their ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071219/DC10329LOGO ), "It,s a ...
... Pa., Dec. 19 Seabrook House,proudly announces ... Living,Facility, Seabrook West. The 90-day program welcomes ... country at the newly renovated,14-acre estate located ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/DC10193-a ), ...
... in tumor-suppressing gene could point to lymph node involvement, ... Supposedly "innocent" cells in the area surrounding cancerous tumors ... can predict whether or not the cancer spreads to ... of alterations in the tumor-suppressing p53 gene in the ...
Other Medicine News:Health News:The Long Term Care Insurance Explosion; January Conference to Celebrate Rapid Growth of LTC Protection and Light Fuse of Further Expansion 2Health News:GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder 2Health News:GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder 3Health News:GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder 4Health News:GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder 5Health News:A 'Happy New You' in the New Year 2Health News:Seabrook House Opens Transitional Living Facility: Seabrook West 2Health News:Seabrook House Opens Transitional Living Facility: Seabrook West 3Health News:Area Around Breast Tumor May Predict Cancer's Spread 2Health News:Area Around Breast Tumor May Predict Cancer's Spread 3
(Date:12/16/2009)... Greenway Medical Technologies, Inc. today announced that its ... management and interoperability solution, Prime Suite® 2011, ... annual 2009 Top 20 Best in KLAS ... ,, For practices having between six and 25 ... in KLAS in ambulatory EMR for the fourth ...
(Date:12/16/2009)... -- Today, Avantium announced the,appointment of Gunnar ... pharmaceutical,business. Gunnar Staaf previously worked at Serentis ... Company, in a range of commercial and ... in Avantium,s plan to,spin-out its pharmaceutical business. ... company based on its offering of proprietary,crystallization ...
(Date:12/16/2009)... and MinuteClinic health care centers located in select ... 20 states and Washington, D.C. While in ... continue, many states have lifted restrictions, allowing all ... while supplies last. In addition, seasonal influenza ... MinuteClinic locations across the country on demand seven ...
Breaking Medicine Technology:Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Avantium Appoints Gunnar Staaf as CEO Pharma 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Tissue Banks International Develops Expanded Ocular Services Division 54739 1Tissue Banks International Develops Expanded Ocular Services Division 54739 2Pre Owned Prices on Premium Pharmaceutical Equipment 13609 1Pre Owned Prices on Premium Pharmaceutical Equipment 13609 2Adamas Pharmaceuticals Signs CRADA With U S Navy to Conduct Preclinical Studies of Triple Combination Antiviral Drug Therapy for Influenza A Includi 4864 1Adamas Pharmaceuticals Signs CRADA With U S Navy to Conduct Preclinical Studies of Triple Combination Antiviral Drug Therapy for Influenza A Includi 4864 2Adamas Pharmaceuticals Signs CRADA With U S Navy to Conduct Preclinical Studies of Triple Combination Antiviral Drug Therapy for Influenza A Includi 4864 3
... Dependent on Outcomes of New Analyses or Confirmatory ... for Tuesday March 18, 2008, BERKELEY HEIGHTS, ... ) announced that the Food and Drug,Administration,s (FDA) ... that available data are not adequate to support ...
... Pivotal Trial Presented at Annual Meeting of ... American Association for Geriatric Psychiatry --, SAN FRANCISCO ... MDVN ) today announced that clinical results from,its first ... in patients with mild-to-moderate Alzheimer,s disease (AD) over,a one-year ...
Other Medicine Technology:FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 2Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 3Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 4
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
... NEW Research Grade Microscope Camera ... a superior imaging technology that delivers ... accuracy at an affordable price. ... high resolution 3.3 mega-pixel digital microscope ...
The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...
Medicine Products: